International Journal of Drug Delivery Technology
Volume 15, Issue 2

4-Hydroxyisoleucine-Loaded Nanogel: Development from an Optimized Nanoemulsion for Antidiabetic Therapy

Naresh Kumar1, Garima Gupta1, Amit Singh1, Rakesh K Sindhu2, Mohammad Rashid3* 

1Department of Pharmacy, Monad University, Hapur, Uttar Pradesh-201310, India

2School of Pharmacy, Sharda University, Greater Noida-201306, India

3R.V. Northland Institute, G.B. Nagar, Dadri, Greater Noida, Uttar Pradesh-203207, India

Received: 15th Apr, 2025; Revised: 27th May, 2025; Accepted: 10th Jun, 2025; Available Online: 25th Jun, 2025 

ABSTRACT

This work focuses on the creation and assessment of a nanogel system produced from an optimal nanoemulsion formulation infused with 4-hydroxyisoleucine, a powerful antidiabetic bioactive agent. Diabetes mellitus affects 425 million people globally, with 82 million in Southeast Asia. The pandemic could lead to cardiovascular disorders, strokes, renal failures, and blindness. Fenugreek has anti-diabetic properties and reduced cholesterol levels in type II diabetes patients. Nano-carriers improve drug bioavailability.

Method: Nanoemulsions were created with an aqueous titration emulsification technique and tailored according to droplet size, polydispersity index (PDI), zeta potential, and entrapment efficiency. The improved nanoemulsion demonstrated advantageous physicochemical characteristics, including nanoscale droplet dimensions and steady dispersion. The optimized nanoemulsion was integrated into a biocompatible gel matrix, resulting in a nanogel with improved stability and regulated drug release properties. The synthesized nanogel was assessed for rheological characteristics, pH, Spreadability, in vitro drug release, and ex vivo skin penetration. The results demonstrated a prolonged release profile and enhanced penetration efficiency, indicating increased transdermal administration of 4-hydroxyisoleucine.

Conclusion: The research investigates the synthesis and characterisation of 4-hydroxy isoleucine (4HILCN), a medication of 99% purity. FTIR spectroscopy was used to identify and describe the medication, assess its purity, and conduct quantitative analysis. The medication was formulated using an optimum composition of three mixtures including oil and Smix and water. The nanoemulsion was transformed into a hydrogel for dermal application using Carbopol-934. The uniformity of the compositions remained stable after being transferred into flint-colored glass containers. The ideal pH range for cosmeceutical assessment is 5.0-6.0. Stability experiments indicated no any variation in parameters which are indicative of the instability. In vitro investigation of drug release kinetics shown enhanced solubility and diffusion rates. Ex-vivo permeation experiments demonstrated superior penetration of drug from 4HILCN-NG compared to Neat Formulation gel of drug and 4HILCN-NEO. The research indicates that the nanogel technology serves as a potential transdermal delivery system for Antidiabetic treatment, providing improved bioavailability and patient adherence.

Keywords: Nanoemulsion, Nano-gel, Permeability, correlation coefficient, Z-average.

How to cite this article: Naresh Kumar, Garima Gupta, Amit Singh, Rakesh K Sindhu, Mohammad Rashid. 4-Hydroxyisoleucine-Loaded Nanogel: Development from an Optimized Nanoemulsion for Antidiabetic Therapy. International Journal of Drug Delivery Technology. 2025;15(2):641-48. doi: 10.25258/ijddt.15.2.34

REFERENCES

  1. IDF Diabetes Atlas Group. IDF Diabetes Atlas Fourth Edition [Internet]. Idf Diabetes Atlas. 2009. 1–527 p. Available from: http://www.diabetesatlas.org/resources/2015-atlas.html%5Cnhttps://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf%5Cnwww.ecuadorencifras.gob.ec
  2. World Health Organization. Global Report on Diabetes. Isbn [Internet]. 2016;978:88. Available from: http://www.who.int/about/licensing/%5Cnhttp://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf
  3. Gothai S, Ganesan P, Park SY, Fakurazi S, Choi DK, Arulselvan P. Natural phyto-bioactive compounds for the treatment of type 2 diabetes: Inflammation as a target. Nutrients. 2016;8(8).
  4. Singh S, Mazumder A, Chakaraborthy GS. Potential herbs against diabetes mellitus - An update. Int J Pharm Sci Res [Internet]. 2019;10(8):3619–26. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L629274509&from=export%0Ahttp://dx.doi.org/10.13040/IJPSR.0975-8232.10(8).3619-26
  5. Santhiveeran J, Ph D, Kim M, Ph D, Ranney M, Ph D. A QUANTITATIVE STUDY ON THE DISEASE MANAGEMENT OF DIABETES AND THE EFFECTS ON MINORITY POPULATIONS Presented to the School of Social Work California State University , Long Beach In Partial Fulfillment of the Requirements for the Degree Master of Social W. 2019;(May).
  6. Anwar S, Desai S, Eidi M, Eidi A. Antidiabetic Activities of Fenugreek (Trigonella foenum-graecum) Seeds. Nuts Seeds Heal Dis Prev. 2011 Jan 1;469–78.
  7. Upadhyay TK, Das S, Mathur M, Alam M, Bhardwaj R, Joshi N, et al. Medicinal plants and their bioactive components with antidiabetic potentials. Antidiabetic Med Plants Appl Oppor. 2023 Jan 1;327–64.
  8. Geberemeskel GA, Debebe YG, Nguse NA. Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients. J Diabetes Res [Internet]. 2019 Jan 1 [cited 2025 Jan 26];2019(1):8507453. Available from: https://onlinelibrary.wiley.com/doi/full/10.1155/2019/8507453
  9. Khursheed R, Singh SK, Wadhwa S, Kapoor B, Gulati M, Kumar R, et al. Treatment strategies against diabetes: Success so far and challenges ahead [Internet]. Vol. 862, European Journal of Pharmacology. Elsevier B.V.; 2019. 172625 p. Available from: https://doi.org/10.1016/j.ejphar.2019.172625
  10. Alam S, Iqbal Z, Ali A, Khar RK, Ahmad FJ, Akhter S, et al. Microemulsion as a potential transdermal carrier for poorly water soluble antifungal drug itraconazole. J Dispers Sci Technol. 2010 Jan;31(1):84–94.
  11. Ganesan P, Arulselvan P, Choi DK. Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - Current status. Int J Nanomedicine. 2017;12:1097–111.
  12. Harwansh RK, Mukherjee PK, Bahadur S, Biswas R. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci [Internet]. 2015;141:202–11. Available from: http://dx.doi.org/10.1016/j.lfs.2015.10.001
  13. Azeem A, Talegaonkar S, Negi LM, Ahmad FJ, Khar RK, Iqbal Z. Oil based nanocarrier system for transdermal delivery of ropinirole: A mechanistic, pharmacokinetic and biochemical investigation. Int J Pharm [Internet]. 2012;422(1–2):436–44. Available from: http://dx.doi.org/10.1016/j.ijpharm.2011.10.039
  14. Rashid M, Sindhu RK, Ahmad FJ. Development and evaluation of optimised nanogel loaded with herbal bioactive antidiabetic agent. Eur Chem Bull. 2023;12(8):435–63.
  15. Amjad Pasha M, Amjad M, Ehtheshamuddin M, Chand S, Sabreesh M, Asia R, et al. FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF ATENOLOL. Adv Res Pharm Biol. 2011;1(2).
  16. Sturm S, Stuppner H. Analysis of cucurbitacins in medicinal plants by high-pressure liquid chromatography-mass spectrometry. Phytochem Anal. 2000;11(2):121–7.
  17. Aslan C, Çelebi N, Değim IT, Atak A, Özer Ç. Development of Interleukin-2 Loaded Chitosan-Based Nanogels Using Artificial Neural Networks and Investigating the Effects on Wound Healing in Rats. AAPS PharmSciTech. 2017;18(4):1019–30.
  18. Sengel-Turk CT, Ozmen N, Bakar-Ates F. Design, characterization and evaluation of cucurbitacin B-loaded core–shell-type hybrid nano-sized particles using DoE approach. Polym Bull [Internet]. 2021;78(6):3327–51. Available from: https://doi.org/10.1007/s00289-020-03256-7
  19. Aiyalu R, Govindarjan A, Ramasamy A. Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model. Brazilian J Pharm Sci. 2016;52(3):493–507.
  20. Khan MA, Pandit J, Sultana Y, Sultana S, Ali A, Aqil M, et al. Drug Delivery Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo Drug Deliv [Internet]. 2015 [cited 2023 May 26];22(6):795–802. Available from: https://www.tandfonline.com/action/journalInformation?journalCode=idrd20http://informahealthcare.com/
  21. Abdhesh, Gupta SK. Formulation and evaluation of nanoemulsion based nanoemulgel of aceclofenac. J Pharm Sci Res. 2020;12(4):524–32.
  22. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012 Jan 1;20(1):63–7.
  23. Sultana S, Talegaonkar S, Bhatnagar A, Ahmad FJ, Mittal G. Optimization of nifedipine loaded gastroretentive microcapsules for biliary colic. Asian J Pharm. 2012;6(4):295–306.
  24. Mutalik S, Udupa N. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin. Pharmazie [Internet]. 2002 Dec 1 [cited 2023 Sep 7];57(12):838–41. Available from: https://europepmc.org/article/med/12561248
  25. Tian Q, Quan P, Fang L, Xu H, Liu C. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention. Int J Pharm. 2021 Oct 25;608:121082.
  26. Attar UA, Ghane SG. Optimized extraction of anti-cancer compound – cucurbitacin I and LC–MS identification of major metabolites from wild Bottle gourd (Lagenaria siceraria (Molina) Standl.). South African J Bot [Internet]. 2018;119:181–7. Available from: https://doi.org/10.1016/j.sajb.2018.09.006
  27. Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications [Internet]. Vol. 270, Journal of Controlled Release. Elsevier B.V; 2018. 203–225 p. Available from: http://dx.doi.org/10.1016/j.jconrel.2017.11.049
  28. Mauri E, Cappella F, Masi M, Rossi F. PEGylation influences drug delivery from nanogels. J Drug Deliv Sci Technol [Internet]. 2018;46(January):87–92. Available from: https://doi.org/10.1016/j.jddst.2018.05.003